ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Inspector General’s chronology Of Events In Gallo Research

July 1, 1994

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

April 27, 2001

ASCO Recommends End of Life Discussions

January 28, 2011

Consensus Panel Determines Total Mastectomy Plus Node Dissection “Satisfactory Alternative” To Radical Mastectomy

June 15, 1979

President’s FY 1992 Budget Seeks $1.81 Billion For NCI, 5.6% Increase, But $800M Below Byspass

February 8, 1991

In Brief: Rhoads Renamed Cancer Advisory Board Chairman; L-B’s Frederick Contract Renewed For $12 Million

June 28, 1974